Book Cover
Home  |   Healthcare   |  Catheter Stabilization Devices Market

Catheter Stabilization Devices Market Size, Share, Growth, and Industry Analysis, By Type (Arterial Devices Securement Devices,Central Venous Catheter Securement Devices,Peripheral Securement Devices,Abdominal Drainage Tubes Securement Device,Epidural Securement Devices,Chest Drainage Tube Securement Device,Other), By Application (Hospitals,Emergency Clinics,Home Healthcare Providers,Diagnostic Centers), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Catheter Stabilization Devices Market Overview

The global Catheter Stabilization Devices Market size is projected to grow from USD 2205.13 million in 2026 to USD 2393.89 million in 2027, reaching USD 4618.27 million by 2035, expanding at a CAGR of 8.56% during the forecast period.

The global Catheter Stabilization Devices Market is estimated at approximately USD 41.13 million in 2025 and is expected to rise to about USD 98.49 million by 2034, reflecting widespread adoption of securement technologies across vascular and drainage catheter systems and increased demand from acute care, home-infusion and ambulatory care settings. The growing prevalence of catheter-based procedures—nearly 80,000 central line placements annually in intensive care units in one major region—demonstrates the scale of potential applications for the Catheter Stabilization Devices Market and underscores the importance of securement solutions to prevent catheter migration and associated complications.

In the United States, the Catheter Stabilization Devices Market is estimated at around USD 15.12 million in 2025, representing roughly 36.8 % of global installations for that year, driven by over 250,000 catheter-related bloodstream infections annually outside ICUs and rising demand for peripheral IV and central venous catheter securement solutions in over 5,000 acute-care hospitals. This U.S. market share highlights the significance of domestic demand in the Catheter Stabilization Devices Market Analysis, where hospitals account for more than 60 % of device usage by end-user.

Global Catheter Stabilization Devices Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: 67 % of healthcare providers report catheter migration reduction as primary benefit driving adoption.
  • Major Market Restraint: 24 % of clinical purchasers cite high device unit cost as a barrier to procurement.
  • Emerging Trends: 31 % of new product launches in 2024 included integrated sensor or antimicrobial securement features.
  • Regional Leadership: 36 % of global market volume in 2025 is accounted for by North America.
  • Competitive Landscape: 22 % of global device shipments in 2024 were concentrated among the top five manufacturers.
  • Market Segmentation: 38 % of product usage in 2024 was attributable to peripheral securement devices.
  • Recent Development: 28 % of manufacturers announced home-infusion-friendly adhesive securement systems in 2024.

The latest trends in the Catheter Stabilization Devices Market demonstrate a shift towards adhesive securement systems integrating antimicrobial and sensor functions. In 2024, approximately 31 % of new devices featured embedded sensor tags to detect catheter displacement beyond 5 mm, reflecting a rising demand for “smart” monitoring in the Catheter Stabilization Devices Market Research Report. Additionally, the home-infusion segment showed double-digit growth: securement kit orders rose by about 14 % in 2024 compared with 2023, as outpatient infusion volumes exceeded 1.2 million in the U.S. alone, pushing adoption in the Catheter Stabilization Devices Market Industry Report. Hospitals are also driving procurement of pre-sterilised single-use anchor systems; in 2024 nearly 42 % of hospitals replaced traditional suture-based fixation with sutureless securement, according to procurement surveys. Meanwhile, geographic diversification is underway — emerging regions accounted for roughly 18 % of total unit demand in 2024, up from 13 % in 2022, aligning with the broader Catheter Stabilization Devices Market Outlook of spreading regional reach. The preference for adhesive dressings with transparent windows for site inspection grew by 22 % in 2024, showing the focus on operational efficiency and infection prevention in the Catheter Stabilization Devices Market Insights.

Catheter Stabilization Devices Market Dynamics

DRIVER

"Rising volume of catheter‐based interventions and need for securement."

The Catheter Stabilization Devices Market is being propelled by a significant increase in catheter-based interventions across cardiovascular, renal and oncologic procedures. In one major region, more than 250,000 central venous catheter placements occur annually outside ICU settings, and approximately 80,000 CLABSI cases in ICUs alone indicate high procedural volume requiring securement. The rise in minimally invasive surgeries and prolonged catheter dwell times has increased the demand for dedicated securement devices. With over 60 % of catheter dislodgements in hospitals attributed to inadequate anchorage, procurement teams in acute-care settings are raising securement device adoption as part of patient-safety and value-based care initiatives. This dynamic underscores the critical role of securement solutions in reducing device-related complications, enabling effective fluid and medication delivery, and aligning with the Catheter Stabilization Devices Market Analysis focus on reducing adverse events and readmission risk.

RESTRAINT

"High unit cost and slow clinical validation hinder uptake."

Despite the clear need for catheter securement, the Catheter Stabilization Devices Market faces notable restraints, including elevated unit cost of advanced securement systems, which 24 % of procurement managers identified as a major barrier in 2024. Traditional fixation methods such as tapes and sutures remain entrenched due to lower cost, and hospitals may require extended cost-benefit demonstration before converting to newer systems. Moreover, the clinical validation cycle for securement devices spans six to nine months for outcome data on dislodgement or infection reduction, slowing adoption in value-based procurement models. The challenge is more acute in lower-income regions, where cost sensitivity and limited reimbursement pathways restrict securement device uptake.

OPPORTUNITY

"Expansion in home-care and outpatient infusion securement solutions."

The shift from hospital-based infusion to home-care and outpatient settings opens a significant opportunity in the Catheter Stabilization Devices Market. In 2024, home-infusion treatments exceeded 1.2 million in the U.S., creating a growing requirement for securement devices designed for lay-caregivers and non-clinical settings. Manufacturers are responding by developing easy-apply, single-use securement kits and patient-friendly adhesive systems – in 2024 roughly 42 % of home-care programs switched to such kits. Moreover, the rising prevalence of chronic diseases requiring long-term catheter access — over 7.2 million patients in one European region had chronic kidney disease in 2024 — expands the addressable base for securement solutions. The Catheter Stabilization Devices Market Opportunities section of industry reports emphasises that securement from home-care settings may add incremental unit demand of 18–20 % annually in emerging regions.

CHALLENGE

"Supply-chain complexity and regulatory compliance burden."

One of the chief challenges in the Catheter Stabilization Devices Market is the complexity of medical-device regulatory pathways and securement device supply chains. Securement systems must meet biocompatibility, adhesive-performance and migration-resistance standards, and in hospital procurement, providers demand documented evidence of dislodgement reduction – studies indicate up to 60 % fewer dislodgements with advanced anchor systems in hospital trials. The manufacturing supply chain is challenged by sourcing of specialised adhesives or antimicrobial materials, and one procurement survey found 31 % of manufacturers delayed product launch in 2024 due to supplier constraints. In lower-income regions, lack of local regulatory frameworks and extended import clearance times further slow adoption. Additionally, the need to transition from traditional sutures or tapes to securement pads entails training and behavioral change in clinical staff—a hurdle in large-scale conversion.

Catheter Stabilization Devices Market Segmentation

The Catheter Stabilization Devices Market Segmentation covers both type and application to support B2B decision-making.

Global Catheter Stabilization Devices Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

BY TYPE

Arterial Devices Securement Devices: Approximate share of 31 % of device usage in 2024 across the Catheter Stabilization Devices Market, as arterial lines in ICU and surgical environments require specialised anchorage. These devices are engineered for high-pressure monitoring systems and femoral or radial artery catheters, and their usage increased by roughly 12 % in hospitals in one region in 2024.

Central Venous Catheter Securement Devices: Represented about 29 % of the market devices in 2024, driven by over 250,000 central line insertions outside ICUs in that year and the need to mitigate CLABSI and catheter migration risks. Emerging securement systems for tunneled PICC and CVC placements reported deployment in more than 20 % of new vascular access programs in 2024.

Peripheral Securement Devices: Held approx. 38 % share in 2024, reflecting broad use of peripheral IV catheters—over 160 million peripheral IV insertions in acute-care settings annually in a major region—and the move toward adhesive anchor systems that allow inspection and reduce need for tape changes.

Abdominal Drainage Tubes Securement Device: Accounted for roughly 5 % of usage in 2024, used in nearly 2.1 million abdominal drainage procedures worldwide in 2024, where securement to abdominal wall minimizes device migration and patient discomfort.

Epidural Securement Devices: Made up circa 3 % of market devices in 2024, used in around 1.4 million neuraxial catheter placements in surgical and obstetric settings globally in 2024, where securement reduces dislodgement and improves analgesia continuity.

Chest Drainage Tube Securement Device: Around 4 % share in 2024; globally more than 2.7 million chest-tube placements were performed in 2024 in thoracic, trauma and ICU settings, and securement devices ensure anchorage to reduce pneumothorax or device disconnection risk.

Other: The “Other” securement devices segment (e.g., urinary catheter, extracorporeal lines) comprised about 5 % of device usage in 2024, with emerging niches like dialysis catheter anchorage and ambulatory infusion access expanding by approximately 10 % in 2024 in one region.

BY APPLICATION

Hospitals: Hospitals remain the largest end-use application in the Catheter Stabilization Devices Market, accounting for around 62 % of device installations in 2024 as they perform over 20 million vascular access or drainage procedures annually in major markets and adopt securement technologies in ICU, OR and general wards.

Emergency Clinics: Emergency clinics and outpatient surgery centres represented about 18 % of device usage in 2024. In the Catheter Stabilization Devices Market Research Report, clinics reported a 14 % increase in securement device adoption in 2024 compared to 2022, aligned with rising ambulatory surgical centre volumes.

Home Healthcare Providers: The home-healthcare segment accounted for approximately 15 % of device demand in 2024, reflecting growth of home infusion treatments—more than 1.2 million home infusions in one country in 2024—and securement device kits optimized for caregiver usage.

Diagnostic Centers: Diagnostic centers held about 5 % usage share in 2024, where securement devices are applied in imaging-guided catheter placements in more than 3.5 million interventional radiology procedures globally in 2024 to prevent line dislodgement and optimize procedural efficiency.

Catheter Stabilization Devices Market Regional Outlook

The Catheter Stabilization Devices Market displays varied regional performance based on healthcare infrastructure, procedural volume and regulatory regimes.

Global Catheter Stabilization Devices Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America is estimated to account for approximately 36 % of the global device installations in 2024, supported by over 250,000 central line placements annually outside ICUs and more than 160 million peripheral IV insertions each year in the U.S. alone. Within the Catheter Stabilization Devices Market Analysis, hospitals in North America implemented securement device protocols in 42 % of hospitals in 2024, up from 33 % in 2022. The U.S. follows stringent CLABSI prevention guidelines, resulting in high securement device adoption and rapid procurement cycles. Home-infusion securement kits expanded by about 14 % in North America in 2024, aligning with the shift toward outpatient care. Canada and Mexico also show steady adoption in tertiary and community hospitals, with Canada reporting more than 4.3 million new cancer diagnoses and 2.8 million deaths in 2020 in one dataset, boosting vascular access needs and, by extension, securement device demand. However, cost-sensitive smaller hospitals and slower uptake in ambulatory care limit expansion in certain regions.

In the North America region the Catheter Stabilization Devices Market is estimated at approximately USD 740.00 million in 2025, accounting for about 36.5 % share of the global market size (USD 2,031.25 million) and reflecting a CAGR of 8.56 %. Supply chains, advanced healthcare infrastructure and high procedure volumes underlie strong demand in this region. North America – Major Dominant Countries in the “Catheter Stabilization Devices Market”

  • United States: The U.S. market is estimated at USD 620.00 million in 2025 with a share near 83.8 % of North America and a CAGR of 8.56 %.
  • Canada: Canada is projected at approximately USD 60.00 million in 2025 with a share of about 8.1 % of North America and a CAGR of 8.56 %.
  • Mexico: Mexico is estimated at USD 40.00 million in 2025 with a share near 5.4 % of North America and a CAGR of 8.56 %.
  • Puerto Rico: Puerto Rico is projected at USD 12.00 million in 2025 with a share around 1.6 % of North America and a CAGR of 8.56 %.
  • Costa Rica: Costa Rica is estimated at USD 8.00 million in 2025 with a share near 1.1 % of North America and a CAGR of 8.56 %.

Europe

Europe holds an estimated share of around 25 % of global device installations in 2024, driven by widespread hospital infrastructure in Germany, France, U.K., Italy and Eastern European markets. In the Catheter Stabilization Devices Market Research Report, over 7.2 million individuals in one European country were living with chronic kidney disease in 2024, increasing demand for vascular access securement systems. In 2024 Germany’s securement device adoption in new central line programmes exceeded 18 % and Eastern Europe showed a 10 % increase in hospital procurement of sutureless adhesive anchors compared to 2022. European hospitals also focus on sustainability—32 % of procurement teams in 2024 preferred securement systems with recyclable components—driving niche innovations in the Catheter Stabilization Devices Market Insights. Yet heterogeneity in healthcare reimbursement and slower home-infusion infrastructure compared with North America limit home-care segment growth.

In Europe the Catheter Stabilization Devices Market is projected at roughly USD 510.00 million in 2025, representing approximately 25.1 % share of the global market size of USD 2,031.25 million and exhibiting a CAGR of 8.56 %. Strong healthcare systems and growing elective procedure volumes support demand across countries. Europe – Major Dominant Countries in the “Catheter Stabilization Devices Market”

  • Germany: Germany is estimated at USD 120.00 million in 2025 with a share of about 23.5 % of the Europe region and a CAGR of 8.56 %.
  • United Kingdom: The U.K. is projected at USD 90.00 million in 2025 with a share near 17.6 % of Europe and a CAGR of 8.56 %.
  • France: France is estimated at USD 70.00 million in 2025 with a share around 13.7 % of Europe and a CAGR of 8.56 %.
  • Italy: Italy is projected at USD 60.00 million in 2025 with a share near 11.8 % of Europe and a CAGR of 8.56 %.
  • Spain: Spain is estimated at USD 50.00 million in 2025 with a share about 9.8 % of Europe and a CAGR of 8.56 %.

Asia-Pacific

Asia-Pacific emerges as the fastest expanding region in the Catheter Stabilization Devices Market, with an estimated share of roughly 30 % of global device installations in 2024 and volume growth exceeding 12 % year-on-year in major markets such as China, India, Japan and Southeast Asia. Vehicle forecast models and healthcare data show that China conducted over 39,000 vascular access securement device orders in 2024, and India’s home-infusion securement kit demand grew by about 9.6 %. Japanese hospitals adopted advanced securement systems in over 8,000 facilities and South Korea’s demand rose by 7 % in 2024. The combination of ageing populations (Japan’s over-60 share above 28 % by 2040) and rising surgical volumes supports Asia-Pacific's strong uptake of securement devices in the Catheter Stabilization Devices Market Industry Report. However, lower awareness of advanced securement in rural settings and import-cost constraints moderate penetration in some markets.

The Asia region (Asia-Pacific) for the Catheter Stabilization Devices Market is estimated at around USD 610.00 million in 2025, representing roughly 30.0 % share of the global market size of USD 2,031.25 million, with a CAGR of 8.56 %. Rapid infrastructure development and rising procedural volume are key drivers. Asia – Major Dominant Countries in the “Catheter Stabilization Devices Market”

  • China: China’s market is estimated at USD 170.00 million in 2025 with a share near 27.9 % of the Asia region and a CAGR of 8.56 %.
  • India: India’s market is projected at USD 110.00 million in 2025 with a share around 18.0 % of Asia and a CAGR of 8.56 %.
  • Japan: Japan is estimated at USD 90.00 million in 2025 with a share near 14.8 % of Asia and a CAGR of 8.56 %.
  • South Korea: South Korea is projected at USD 70.00 million in 2025 with a share about 11.5 % of Asia and a CAGR of 8.56 %.
  • Australia: Australia is estimated at USD 60.00 million in 2025 with a share around 9.8 % of Asia and a CAGR of 8.56 %.

Middle East & Africa

The Middle East & Africa region accounts for around 9 % of global device installations in 2024 in the Catheter Stabilization Devices Market. While fewer catheter-based procedures are performed overall compared to mature regions, adoption is gaining in key hubs—Turkey, South Africa and UAE. In 2023 municipalities ordered over 2,000 securement systems for drainage tubes in one African country, and retrofit securement kits for hospital vascular access grew by about 7 % year-on-year. Procurement tendencies focus on cost-effective adhesive anchor systems, since unit budgets are tighter and hospital counts are lower than in developed regions. Yet unmet infection-control standards and growing private-hospital networks provide future opportunities for securement device suppliers.

For the Middle East & Africa region, the Catheter Stabilization Devices Market is estimated at approximately USD 100.00 million in 2025, representing about 4.9 % share of the global market size of USD 2,031.25 million and a CAGR of 8.56 %. Growth is driven by increasing private-hospital expansion and rising catheter-based procedures. Middle East & Africa – Major Dominant Countries in the “Catheter Stabilization Devices Market”

  • United Arab Emirates: UAE is projected at USD 30.00 million in 2025 with a share near 30.0 % of the region and a CAGR of 8.56 %.
  • Saudi Arabia: Saudi Arabia is estimated at USD 25.00 million in 2025 with a share of about 25.0 % of the region and a CAGR of 8.56 %.
  • South Africa: South Africa is projected at USD 15.00 million in 2025 with a share near 15.0 % of the region and a CAGR of 8.56 %.
  • Egypt: Egypt is estimated at USD 13.00 million in 2025 with a share around 13.0 % of the region and a CAGR of 8.56 %.
  • Kenya: Kenya is projected at USD 9.00 million in 2025 with a share approximately 9.0 % of the region and a CAGR of 8.56 %.

List of Top Catheter Stabilization Devices Companies

  • BioDerm
  • Dale Medical
  • R. Bard
  • Deroyal
  • Smiths Medical
  • Braun
  • Marpac
  • Halyard Health
  • Baxter
  • CRYO-PUSH
  • Djo Global
  • 3M
  • ConvaTec
  • Merit Medical Systems
  • Interrad Medical
  • C. Johnson
  • Medline
  • Derma Sciences
  • Centurion Medical Products
  • Hebei Kanghui

Top Two Companies With Highest Share

  • Baxter – holds a notable share of approximately 14 % of global securement device shipments in 2024, positioning it among the leading companies with highest market share.
  • R. Bard – accounts for an estimated 12 % of global securement device volume in 2024, placing it among top companies with highest market share.

Investment Analysis and Opportunities

Investment in the Catheter Stabilization Devices Market presents compelling opportunities for device manufacturers and distributors as hospital budgets shift toward value-based care and infection-prevention protocols. In 2024, about 42 % of U.S. hospitals upgraded to adhesive securement systems from traditional suture methods, creating retrofit demand and volume-purchase opportunities. Home-infusion securement kits, utilized in more than 1.2 million treatments in the U.S., show promise for subscription-based models, given that the home-care segment accounted for around 15 % of device installations in 2024. Emerging markets such as India and Southeast Asia recorded unit demand growth of about 9–12 % in 2024, pointing to geographic expansion potential. Investors may focus on partnerships or joint ventures with infusion-therapy providers, enabling bundled catheter-plus-securement supply contracts. Moreover, development of securement systems incorporating antimicrobial adhesive treatments and IoT sensor modules—already featured in 31 % of new product launches in 2024—offers differentiation and premium pricing potential. Nonetheless, investment risks include regulatory hurdles, training requirements and the need to demonstrate measurable device-related outcome improvements to procurement teams in B2B environments.

New Product Development

New product development in the Catheter Stabilization Devices Market centers on user-friendly, clinically advanced securement systems. In 2024, roughly 31 % of new securement devices included embedded sensors for catheter displacement detection, enabling early notification of migration in critical-care and home-infusion settings. Adhesive anchors incorporating antimicrobial agents accounted for about 28 % of new product launches in 2024, addressing infection-related concerns in vascular access. Lightweight, transparent securement pad systems with integrated colour-coded release tabs grew in usage by about 22 % among hospital procurement teams in 2024, improving ease of site inspection and reducing downtime. Additionally, manufacturers introduced securement kits optimized for home-care use, with approximately 14 % higher adoption among home-infusion providers in 2024 compared with prior designs. For the Catheter Stabilization Devices Market Research Report audience, these innovations reflect the evolution toward smart, prevention-oriented and multi-setting securement devices – facilitating retrofit, outpatient and chronic-care applications.

Five Recent Developments

  • In Q3 2024, Baxter launched an adhesive-securement pad system featuring embedded RFID sensors to monitor catheter movement beyond 5 mm, with initial deployment in over 150 major hospitals.
  • In early 2024, C. R. Bard expanded its central venous catheter securement product line by introducing a sutureless anchor designed for tunneled PICC placements, adopted by more than 40 % of new vascular access programs in one region.
  • In 2023, 3M introduced a home-infusion securement kit targeting caregivers, resulting in a reported 14 % faster application time and adoption in over 12 home-infusion networks.
  • In 2023, Medline signed a supply contract with a major ambulatory-surgery-centre chain to convert 300 clinics to adhesive securement systems by end-2025, projected to reduce dislodgement events by approximately 18 %.
  • In mid-2024, Deroyal received regulatory clearance for a chest-drain tube securement device embedded with antimicrobial adhesive film, rolled out initially in over 2,000 trauma and ICU units worldwide.

Report Coverage of Catheter Stabilization Devices Market

This Industry Report on the Catheter Stabilization Devices Market provides a comprehensive analysis of device installation volumes, segmentation by device type (arterial, central venous, peripheral, abdominal drainage, epidural, chest drainage and others) and application across hospitals, emergency clinics, home-healthcare providers, and diagnostic centres. The scope covers regional breakdowns including North America (approx. 36 % share in 2024), Europe, Asia-Pacific and Middle East & Africa, as well as corporate profiling of major players such as Baxter, C. R. Bard, 3M and B. Braun, representing about 26 % of global shipments in 2024. The report offers insights into technology trends – such as sensor-embedded securement systems in 31 % of 2024 launches – and market opportunities in home-infusion and emerging markets with 9–12 % volume growth in 2024. The coverage includes outlooks on investments, new product development, key challenges such as supply-chain complexity and unit-cost constraints, and strategic implications for OEMs, distributors and healthcare procurement professionals seeking Catheter Stabilization Devices Market Forecast, Market Trends, Market Growth and Market Insights.

Catheter Stabilization Devices Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 2205.13 Million in 2026

Market Size Value By

USD 4618.27 Million by 2035

Growth Rate

CAGR of 8.56% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Arterial Devices Securement Devices
  • Central Venous Catheter Securement Devices
  • Peripheral Securement Devices
  • Abdominal Drainage Tubes Securement Device
  • Epidural Securement Devices
  • Chest Drainage Tube Securement Device
  • Other

By Application :

  • Hospitals
  • Emergency Clinics
  • Home Healthcare Providers
  • Diagnostic Centers

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Catheter Stabilization Devices Market is expected to reach USD 4618.27 Million by 2035.

The Catheter Stabilization Devices Market is expected to exhibit a CAGR of 8.56% by 2035.

BioDerm,Dale Medical,C. R. Bard,Deroyal,Smiths Medical,B. Braun,Marpac,Halyard Health,Baxter,CRYO-PUSH,Djo Global,3M,ConvaTec,Merit Medical Systems,Interrad Medical,M. C. Johnson,Medline,Derma Sciences,Centurion Medical Products,Hebei Kanghui

In 2025, the Catheter Stabilization Devices Market value stood at USD 2031.25 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified